Carbon dots (CDs) have emerged as a distinct class of fluorescent nanomaterials distinguished by their tunable physicochemical properties, ultrasmall size, exceptional photoluminescence, versatile surface chemistry, high biocompatibility, and chemical stability, positioning them as promising candidates for biomedical applications ranging from sensing and imaging to drug delivery and theranostics. As CDs increasingly transition toward biological and clinical use, a fundamental understanding of their interactions with biological membranes becomes essential, as cellular membranes govern nanoparticle uptake, intracellular transport, and therapeutic performance. Model membrane systems, such as phospholipid vesicles and liposomes, offer controllable platforms to elucidate CD-membrane interactions by isolating key physicochemical variables otherwise obscured in complex biological environments. Recent studies demonstrate that CD surface chemistry, charge, heteroatom doping, size, and hydrophobicity, together with membrane composition, packing density, and phase behavior, dictate nanoparticle adsorption, insertion, diffusion, and membrane perturbation. In addition, CD-liposome hybrid systems have gained momentum as multifunctional nanoplatforms that couple the fluorescence and traceability of CDs with the encapsulation capacity and biocompatibility of lipid vesicles, enabling imaging-guided drug delivery and responsive theranostic systems. This review consolidates current insights into the mechanistic principles governing CD interactions with model membranes and highlights advances in CD-liposome hybrid nanostructures. By bridging fundamental nanoscale interactions with translational nanomedicine strategies, this work provides a framework for the rational design of next-generation CD-based biointerfaces with optimized structural, optical, and biological performance.
Nusair et al. (Tue,) studied this question.